相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
Karthic Chandran et al.
ONCOTARGET (2016)
Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner
Antonio Simone Lagana et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives
Vaclav Vetvicka et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema
Chihiro Ozawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway
Semir Beyaz et al.
CLINICAL CANCER RESEARCH (2016)
Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
Mohammad Zarei et al.
DIABETES (2016)
The PPARα Agonist Fenofibrate Improves the Musculoskeletal Effects of Exercise in Ovariectomized Rats
M. P. Mosti et al.
ENDOCRINOLOGY (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Alexandra Montagner et al.
GUT (2016)
Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives
Cristiana Paul et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α
Terry D. Hinds et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
Giovanni Sarnelli et al.
PLOS ONE (2016)
High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
Julie Tomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer
Simone Polvani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin
Salvatore Giovanni Vitale et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
Daniela Rovito et al.
ONCOTARGET (2016)
PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions
X. Wang et al.
ONCOGENESIS (2016)
PPARα modulates gene expression profiles of mitochondrial energy metabolism in oral tumorigenesis
Yi-Ping Huang et al.
BIOMEDICINE-TAIWAN (2016)
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives
Antonio Simone Lagana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease
Vincenza Sofo et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation
Emma Barroso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Activation of PPAR- induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells
Xi Fang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ
Soumyasri Das Gupta et al.
CANCER PREVENTION RESEARCH (2015)
HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice
Avik Roy et al.
CELL METABOLISM (2015)
PPARα regulates tumor progression, foe or friend?
Jiaming Gao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Early investigational drugs targeting PPAR-α for the treatment of metabolic disease
Zhong-Min Liu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
Xiaoling Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Ligand-activated PPARδ upregulates α-smooth muscle actin expression in human dermal fibroblasts: A potential role for PPARδ in wound healing
Sun Ah Ham et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2015)
Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity
Marta Toral et al.
JOURNAL OF HYPERTENSION (2015)
Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
Hyung Kyu Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages
Marina Kemmerer et al.
PLOS ONE (2015)
Establishing the Role of PPARβ/δ in Carcinogenesis
Jeffrey M. Peters et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
PPARα Is Required for PPAδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
Wojciech G. Garbacz et al.
PPAR RESEARCH (2015)
PPARα induces cell apoptosis by destructing Bcl2
Jiaming Gao et al.
ONCOTARGET (2015)
The Pleiotropic Effects of Vitamin D in Gynaecological and Obstetric Diseases: An Overview on a Hot Topic
Francesca Colonese et al.
BIOMED RESEARCH INTERNATIONAL (2015)
PPAR gamma gene - A review
C. Janani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
Limei Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism
Emmanuelle Roche et al.
CELLULAR SIGNALLING (2014)
Polyyne Hybrid Compounds from Notopterygium incisum with Peroxisome Proliferator-Activated Receptor Gamma Agonistic Effects
Xin Liu et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Regulation of lipoprotein lipase by AngptI4
Wieneke Dijk et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling Pathway
Ning Zhang et al.
ONCOTARGET (2014)
Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Bertrand Cariou et al.
DIABETES CARE (2013)
L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression
Yao-Jen Liang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells
Marianna Terrasi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor α
Katarzyna Wejksza et al.
JOURNAL OF IMMUNOLOGY (2013)
Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Francisco A. Monsalve et al.
MEDIATORS OF INFLAMMATION (2013)
Role of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells
Jeffrey D. Coleman et al.
PPAR RESEARCH (2013)
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis
Lingyan Wu et al.
BLOOD (2012)
PPARγ Agonists Target Aromatase Via Both PGE2 and BRCA1
Ofer Margalit et al.
CANCER PREVENTION RESEARCH (2012)
被撤回的出版物: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1 (Retracted article. See vol. 15, 2022)
Kotha Subbaramaiah et al.
CANCER PREVENTION RESEARCH (2012)
Stromal adipocyte PPAR protects against breast tumorigenesis
Graham Skelhorne-Gross et al.
CARCINOGENESIS (2012)
Inhibitory effect of PPARγ on NR0B1 in tumorigenesis of lung adenocarcinoma
Yoshiyuki Susaki et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ
Jin-Hee Park et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
The Development of Subcutaneous Sarcomas in Rodents Exposed to Peroxisome Proliferators Agonists: Hypothetical Mechanisms of Action and De-Risking Attitude
Ingrid M. Pruimboom-Brees et al.
TOXICOLOGIC PATHOLOGY (2012)
PPARs and Lipid Ligands in Inflammation and Metabolism
Gregory S. Harmon et al.
CHEMICAL REVIEWS (2011)
A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
R. A. Ngala et al.
DIABETES OBESITY & METABOLISM (2011)
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Jang Hyun Choi et al.
NATURE (2011)
The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans
Ashish Shah et al.
ATHEROSCLEROSIS (2010)
Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
Jean-Charles Fruchart
ATHEROSCLEROSIS (2009)
Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive
John Dormandy et al.
DRUG SAFETY (2009)
Regulation of Peroxisome Proliferator-Activated Receptor-α by MDM2
Lakshmi Gopinathan et al.
TOXICOLOGICAL SCIENCES (2009)
Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats
Bu-Chin Yu et al.
CARDIOVASCULAR RESEARCH (2008)
Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein
Lakshmi Gopinathan et al.
PPAR RESEARCH (2008)
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
Mark A. Deeg et al.
PPAR RESEARCH (2008)
Adipogenesis and lipotoxicity:: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1)
Gema Medina-Gomez et al.
PUBLIC HEALTH NUTRITION (2007)
Transcriptional network governing the angiogenic, switch in human pancreatic cancer
Amir Abdollahi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fenofibrate represses interleukin-17 and interferon-γ expression and improves colitis in interleukin-10-deficient mice
Jimmy W. Lee et al.
GASTROENTEROLOGY (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism
Gema Medina-Gomez et al.
PLOS GENETICS (2007)
N-3 fatty acids preserve insulin sensitivity in vivo in a peroxisonte proliferator-activated receptor-α-dependent manner
Susanne Neschen et al.
DIABETES (2007)
Intestinal-specific PPARγ deficiency enhances tumorigenesis in ApcMin/+ mice
Christen A. McAlpine et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation
JK Reddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
JN Feige et al.
PROGRESS IN LIPID RESEARCH (2006)
PPARγ-mediated insulin sensitization:: the importance of fat versus muscle
U Kintscher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Roles of PPARs in health and disease
S Kersten et al.
NATURE (2000)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
